Quick Read Guggenheim trimmed its Amgen (AMGN) stock price target to $340 from $351 while maintaining Neutral, reflecting a ...

Amgen's new research campus will begin construction this month. (Rendering c/o Amgen) Thousand Oaks-based biotech giant Amgen Inc. announced this month that it plans to invest more than $600 million ...

History shows dividend stocks often outperform when the Fed pivots to rate cuts, setting up an interesting 2025 backdrop. Amgen's shares have slipped 3.37% in 2024 despite the S&P 500's 26.8% surge, ...

Amgen, Ventura County's largest private-sector employer, is planning a $600 million research facility at its Thousand Oaks ...

Amgen is scrapping an experimental weight loss pill but moving forward with an injection. Amgen will release initial data from a mid-stage study on its injectable drug later this year, and the company ...

Financial giants have made a conspicuous bullish move on Amgen. Our analysis of options history for Amgen (NASDAQ:AMGN) revealed 8 unusual trades. Delving into the details, we found 37% of traders ...

Amgen is posting strong growth across its diversified-medicines portfolio. A new weight-loss drug candidate could be a game-changer for the company. Trading at 17 times earnings, the stock offers good ...

A mgen will invest $900 million in an expansion of its Central Ohio biomanufacturing operations, bringing total investment in the state to over $1.4 billion. With the addition of 350 new jobs, the ...